1. Home
  2. BCAX vs GSM Comparison

BCAX vs GSM Comparison

Compare BCAX & GSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BCAX
  • GSM
  • Stock Information
  • Founded
  • BCAX 2018
  • GSM 2015
  • Country
  • BCAX United States
  • GSM United Kingdom
  • Employees
  • BCAX N/A
  • GSM N/A
  • Industry
  • BCAX
  • GSM Metal Mining
  • Sector
  • BCAX
  • GSM Basic Materials
  • Exchange
  • BCAX NYSE
  • GSM Nasdaq
  • Market Cap
  • BCAX 733.5M
  • GSM 739.5M
  • IPO Year
  • BCAX 2024
  • GSM N/A
  • Fundamental
  • Price
  • BCAX $13.00
  • GSM $3.48
  • Analyst Decision
  • BCAX Strong Buy
  • GSM
  • Analyst Count
  • BCAX 6
  • GSM 0
  • Target Price
  • BCAX $39.50
  • GSM N/A
  • AVG Volume (30 Days)
  • BCAX 327.7K
  • GSM 794.8K
  • Earning Date
  • BCAX 03-04-2025
  • GSM 02-19-2025
  • Dividend Yield
  • BCAX N/A
  • GSM 1.15%
  • EPS Growth
  • BCAX N/A
  • GSM N/A
  • EPS
  • BCAX N/A
  • GSM 0.03
  • Revenue
  • BCAX N/A
  • GSM $1,643,939,000.00
  • Revenue This Year
  • BCAX N/A
  • GSM $2.06
  • Revenue Next Year
  • BCAX N/A
  • GSM $6.65
  • P/E Ratio
  • BCAX N/A
  • GSM $124.91
  • Revenue Growth
  • BCAX N/A
  • GSM N/A
  • 52 Week Low
  • BCAX $11.10
  • GSM $3.45
  • 52 Week High
  • BCAX $28.09
  • GSM $6.19
  • Technical
  • Relative Strength Index (RSI)
  • BCAX N/A
  • GSM 28.73
  • Support Level
  • BCAX N/A
  • GSM $3.80
  • Resistance Level
  • BCAX N/A
  • GSM $3.97
  • Average True Range (ATR)
  • BCAX 0.00
  • GSM 0.16
  • MACD
  • BCAX 0.00
  • GSM -0.04
  • Stochastic Oscillator
  • BCAX 0.00
  • GSM 3.85

About BCAX BICARA THERAPEUTICS INC

Bicara Therapeutics Inc is a clinical-stage biopharmaceutical company bringing transformative bifunctional therapies to patients with solid tumors. Its program ficerafusp alfa is a bifunctional antibody that combines two clinically validated targets, an epidermal growth factor receptor, or EGFR, directed monoclonal antibody with a domain that binds to human transforming growth factor beta, or TGF-b.

About GSM Ferroglobe PLC

Ferroglobe PLC provides silicon-based alloys and specialty metals. It produces silicon metal and silicon and manganese-based alloy, serving customers in the specialty chemical, aluminum, solar, steel and ductile iron foundry industries. The company's business segments include North America - Silicon; Europe - Manganese; Europe - Silicon; South Africa - Silicon and Other segments The primary raw materials company uses to produce its electrometallurgy products includes its coal and quartz mining operations and its silicon metal and ferroalloy production.

Share on Social Networks: